Literature DB >> 3828364

beta-Muricholic acid; potentiometric and cholesterol-dissolving properties.

J C Montet, M Parquet, E Sacquet, A M Montet, R Infante, J Amic.   

Abstract

Some physicochemical properties of beta-muricholic acid (3 alpha,6 beta,7 beta-trihydroxy-5 beta-cholanic acid), a major bile acid biosynthesized by rat liver, were determined and compared to those of ursodeoxycholic and chenodeoxycholic acids. From potentiometric studies, the following characteristics of beta-muricholic acid were shown: a low monomer solubility (13 microM), a high equilibrium precipitation pH (7.92 for 30 mM solution), an apparent critical micellar concentration of 4 mM, and a very low micellar capacity of the bile salt to dissolve the protonated bile acid. Sodium beta-muricholate solution (30 mM) poorly solubilized cholesterol, as indicated by a bile salt/cholesterol molar ratio of 1430, whereas saturation ratios obtained with chenodeoxycholate and ursoseoxycholate were 24 and 384, respectively. Sodium beta-muricholate (30 mM)/phosphatidylcholine/cholesterol mixtures contained non-micellar aggregates from very low cholesterol concentrations. At physiological phosphatidylcholine concentrations, sodium beta-muricholate (100 mM) dissolved cholesterol crystals via essentially lamellar liquid-crystal formation. These solubilizing properties might have important physiological relevance to the dissolution of cholesterol gallstones in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828364     DOI: 10.1016/0005-2760(87)90002-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8.

Authors:  Henning Wittenburg; Martin C Carey
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 3.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

4.  Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.

Authors:  P E Queneau; P Bertault-Peres; M Guitaoui; E Mesdjian; A Durand; J C Montet
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

5.  Hydrophilic bile acids: prevention and dissolution experiments in two animal models of cholesterol cholelithiasis.

Authors:  B I Cohen; T Mikami; N Ayyad; A Ohshima; R Infante; E H Mosbach
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

6.  Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.

Authors:  Folke Freudenberg; Annemarie L Broderick; Bian B Yu; Monika R Leonard; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

7.  Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.

Authors:  R P Oude Elferink; R Ottenhoff; M van Wijland; J J Smit; A H Schinkel; A K Groen
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption.

Authors:  Bethan L Clifford; Leslie R Sedgeman; Kevin J Williams; Pauline Morand; Angela Cheng; Kelsey E Jarrett; Alvin P Chan; Madelaine C Brearley-Sholto; Annika Wahlström; Julianne W Ashby; William Barshop; James Wohlschlegel; Anna C Calkin; Yingying Liu; Anders Thorell; Peter J Meikle; Brian G Drew; Julia J Mack; Hanns-Ulrich Marschall; Elizabeth J Tarling; Peter A Edwards; Thomas Q de Aguiar Vallim
Journal:  Cell Metab       Date:  2021-07-15       Impact factor: 31.373

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.